In addition, transfecting CRC cells with K139R-mutated IGF2BP2 could fully reverse or even enhance the proliferation impaired by LINRIS (Additional file 9: Figure S4F), further confirming the mechanism of the LINRIS-IGF2BP2-MYC axis. This evidence concerns the gene IGF2BP2 and colorectal carcinoma.